Richard Baird

Breast Cancer and Drug Development Specialist @CRUKCambridge @NHS. Tweets are my own and not medical advice.

[Richard Baird @Richard_Baird]

The future of UK medical research is at risk, including pioneering projects that I work on for @CRUK_Policy.

@DanielZeichner as my MP, please sign this letter to show your support and help us continue to make progress for patients https://t.co/oYHDyAVQBi

#ResearchAtRisk

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

Dr Richard Baird, pictured here with Chief Investigator Prof Nicholas Turner and ICR-CTSU’s Sarah Kernaghan, presented the results from plasmaMATCH treatment Cohort D, which assessed the effectiveness of capivasertib in patients with an AKT activation basket mutation #SABCS19

[Richard Baird @Richard_Baird]

If you believe the world deserves a slower, wiser news, now’s your last chance to join Tortoise as a founding member. Kickstarter ends 6pm UK time today. #slowdownwiseup https://t.co/Xpe76l0vEg§

[Richard Baird @Richard_Baird]

@MendeleySupport I have the same problem described below: When I open a web page I would I want to import, I click on the mendeley icon on the browser menu. This open a pop with information to sign in. When the sign in button is clicked, the pop up returns again & again. Can you help?

[Eleonora Teplinsky, MD, FASCO @drteplinsky]

Good overview of #Immunotherapy in metastatic triple negative breast cancer. #ASCO18 #bcsm

[Matthew Katz, MD 🇺🇸🟦 @subatomicdoc]

Hypofractionnated stereotactic radiotherapy and anti-PDL1 durvalumab combination in recurrent glioblastoma: Results of the phase I part of the phase I/II STERIMGLI trial https://t.co/nvQfkw9mqo #ASCO18 #btsm #radonc

[METUP @METUPorg]

Ending the week remembering the 791 men & women who died this week of #metastaticBC - Week after week this number never changes. #ASCO18 #BCSM

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

There’s an app which will change your pics (weird angle, back of heads, see #1) to a real slide (normal angle, see #2). It’s called U scanner. - OR - you can follow the presentation live on your device and screen shot directly on your device.
You are welcome. #ASCO18

[The ASCO Post @ASCOPost]

Geoffrey Oxnard of @DanaFarber on #genomewidesequencing for #lungcancer from #plasmacellfreeDNA #ASCO18

[The ASCO Post @ASCOPost]

Potential for breakthroughs great, though challenges remain in cancer care, says NCI Director Dr. Ned Sharpless, at #ASCO18

[Andy Biotech @AndyBiotech]

#ASCO18 $LOXO-292 beautiful waterfall plot! Congrats @AlexDrilon @VivekSubbiah!

77% ORR in RET fusion+ NSCLC should start putting it in the same league as ALK, ROS1, T790M etc. Durability of response and how $BPMC data evolve will be the next key thing to watch.

[Alice Walsh @sciencealice]

Emoji can be used to measure PROs in cancer patients! Current status: 😎 #ASCO18

[Murray Aitken @Murray_Aitken]

Oncology innovation is high. Over the past 5 years, 78 #cancer drugs have been launched covering 24 different #tumor types with some for the treatment of multiple tumor types. Learn more >> https://t.co/S0MhgeQWUa

#ASCO18

[Philippe Aftimos, MD  @aftimosp]

Bob Li from @sloan_kettering presenta the results of a basket trial testing T-DM1 in non-breast tumors with HER2 amplification. Responses seen in tumor types such as lung cancer, endometrial cancer and salivary gland. No responses in colorectal cancer and urothelial #ASCO18

[Dr. Antonio Calles 🫁🚭 @Tony_Calles]

🤩 Wow!!! Interact, powered by SYNC, is an incredibly amazing feature that allow you to view speaker slides on your personal device in real time #ASCO18 #LCSM Congratulations @ASCO @ASCOPres for this great idea!!! Improving every year!!! 👏👏👏

[Michael Fisch MD MPH @fischmd]

MATCH trial results at #ASCO18: sobering reality of precision guided trial enrollment—not always a home run.

[Richard Simcock @BreastDocUK]

For people wondering where we are with #ASCO18 tweets we are just nearing the peak of the 'Slope of Arrival'

[Dr. Antonio Calles 🫁🚭 @Tony_Calles]

This is what makes @ASCO meeting so special over others. 6yrs survivor ALK+ lung cancer patient standing up giving thanks #ASCO17 #lcsm

[Richard Baird @Richard_Baird]

Phase 1b PK results from CamBMT1 are exciting - we now need to crack on with recruitment to phase 2 ! https://t.co/5oPfNNepcd

[Richard Baird @Richard_Baird]

CamBMT1 phase 1b results presented at ASCO showing that afatinib concentrations are >15-fold higher in brain than plasma after radiotherapy